SunWay Biotech Co., LTD. Statistics

Total Valuation

SunWay Biotech Co., LTD. has a market cap or net worth of TWD 5.14 billion. The enterprise value is 5.10 billion.

Market Cap	5.14B
Enterprise Value	5.10B

Important Dates

The last earnings date was Thursday, November 14, 2024.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

SunWay Biotech Co., LTD. has 59.39 million shares outstanding. The number of shares has increased by 259.82% in one year.

Current Share Class	n/a
Shares Outstanding	59.39M
Shares Change (YoY)	+259.82%
Shares Change (QoQ)	+126.20%
Owned by Insiders (%)	2.68%
Owned by Institutions (%)	n/a
Float	32.39M

Valuation Ratios

The trailing PE ratio is 42.80.

PE Ratio	42.80
Forward PE	n/a
PS Ratio	5.24
PB Ratio	1.60
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 27.80, with an EV/FCF ratio of -320.22.

EV / Earnings	51.22
EV / Sales	6.29
EV / EBITDA	27.80
EV / EBIT	43.98
EV / FCF	-320.22

Financial Position

The company has a current ratio of 3.57, with a Debt / Equity ratio of 0.09.

Current Ratio	3.57
Quick Ratio	2.42
Debt / Equity	0.09
Debt / EBITDA	1.49
Debt / FCF	-17.21
Interest Coverage	28.27

Financial Efficiency

Return on equity (ROE) is 5.40% and return on invested capital (ROIC) is 3.41%.

Return on Equity (ROE)	5.40%
Return on Assets (ROA)	3.21%
Return on Capital (ROIC)	3.41%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.36
Inventory Turnover	2.57

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +6.97% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+6.97%
50-Day Moving Average	88.49
200-Day Moving Average	103.58
Relative Strength Index (RSI)	41.36
Average Volume (20 Days)	40,527

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SunWay Biotech Co., LTD. had revenue of TWD 810.99 million and earned 99.60 million in profits. Earnings per share was 2.02.

Revenue	810.99M
Gross Profit	423.25M
Operating Income	116.16M
Pretax Income	118.97M
Net Income	99.60M
EBITDA	157.76M
EBIT	116.16M
Earnings Per Share (EPS)	2.02

Full Income Statement

Balance Sheet

The company has 312.16 million in cash and 274.19 million in debt, giving a net cash position of 37.97 million or 0.64 per share.

Cash & Cash Equivalents	312.16M
Total Debt	274.19M
Net Cash	37.97M
Net Cash Per Share	0.64
Equity (Book Value)	3.21B
Book Value Per Share	54.04
Working Capital	595.73M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 80.79 million and capital expenditures -96.72 million, giving a free cash flow of -15.93 million.

Operating Cash Flow	80.79M
Capital Expenditures	-96.72M
Free Cash Flow	-15.93M
FCF Per Share	-0.27

Full Cash Flow Statement

Margins

Gross margin is 52.19%, with operating and profit margins of 14.32% and 12.28%.

Gross Margin	52.19%
Operating Margin	14.32%
Pretax Margin	14.67%
Profit Margin	12.28%
EBITDA Margin	19.45%
EBIT Margin	14.32%
FCF Margin	-1.96%

Dividends & Yields

This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 1.14%.

Dividend Per Share	1.00
Dividend Yield	1.14%
Dividend Growth (YoY)	-68.76%
Years of Dividend Growth	n/a
Payout Ratio	87.56%
Buyback Yield	-259.82%
Shareholder Yield	-258.68%
Earnings Yield	2.34%
FCF Yield	-0.31%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SunWay Biotech Co., LTD. has an Altman Z-Score of 5.69.

Altman Z-Score	5.69
Piotroski F-Score	n/a